Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176505 | SCV000228173 | pathogenic | not provided | 2013-10-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001246215 | SCV001419556 | pathogenic | Nephronophthisis | 2022-06-20 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 96516). This premature translational stop signal has been observed in individual(s) with nephronopthisis (PMID: 23188109). This variant is present in population databases (rs368138001, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.Arg1125*) in the NPHP3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHP3 are known to be pathogenic (PMID: 18371931, 23559409). |
Fulgent Genetics, |
RCV002483155 | SCV002778343 | pathogenic | Renal-hepatic-pancreatic dysplasia 1; Nephronophthisis 3; NPHP3-related Meckel-like syndrome | 2022-02-25 | criteria provided, single submitter | clinical testing |